BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26356631)

  • 1. Protein-polymer conjugation-moving beyond PEGylation.
    Qi Y; Chilkoti A
    Curr Opin Chem Biol; 2015 Oct; 28():181-93. PubMed ID: 26356631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic protein-polymer conjugates: advancing beyond PEGylation.
    Pelegri-O'Day EM; Lin EW; Maynard HD
    J Am Chem Soc; 2014 Oct; 136(41):14323-32. PubMed ID: 25216406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer Based Protein Therapeutics.
    Bhawani SA; Husaini A; Ahmad FB; Asaruddin MR
    Curr Protein Pept Sci; 2018; 19(10):972-982. PubMed ID: 28828988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry for peptide and protein PEGylation.
    Roberts MJ; Bentley MD; Harris JM
    Adv Drug Deliv Rev; 2002 Jun; 54(4):459-76. PubMed ID: 12052709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methods.
    Mero A; Clementi C; Veronese FM; Pasut G
    Methods Mol Biol; 2011; 751():95-129. PubMed ID: 21674328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zwitterionic Polymer: A New Paradigm for Protein Conjugation beyond PEG.
    Zeng Z; Chen S; Chen Y
    ChemMedChem; 2023 Oct; 18(20):e202300245. PubMed ID: 37675618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Polymer Bioconjugation on Protein Stability and Activity Investigated with Discrete Conjugates: Alternatives to PEGylation.
    Morgenstern J; Gil Alvaradejo G; Bluthardt N; Beloqui A; Delaittre G; Hubbuch J
    Biomacromolecules; 2018 Nov; 19(11):4250-4262. PubMed ID: 30222929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylation: an approach for drug delivery. A review.
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2008; 25(5):403-47. PubMed ID: 19062633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
    Zhang P; Sun F; Liu S; Jiang S
    J Control Release; 2016 Dec; 244(Pt B):184-193. PubMed ID: 27369864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
    Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Product development issues for PEGylated proteins.
    Payne RW; Murphy BM; Manning MC
    Pharm Dev Technol; 2011 Oct; 16(5):423-40. PubMed ID: 20858059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(Oxanorbornene)-Protein Conjugates Prepared by Grafting-to ROMP as Alternatives for PEG.
    Davis E; Caparco AA; Steinmetz NF; Pokorski JK
    Macromol Biosci; 2024 Feb; 24(2):e2300255. PubMed ID: 37688508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques.
    Francis GE; Fisher D; Delgado C; Malik F; Gardiner A; Neale D
    Int J Hematol; 1998 Jul; 68(1):1-18. PubMed ID: 9713164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide and protein PEGylation: a review of problems and solutions.
    Veronese FM
    Biomaterials; 2001 Mar; 22(5):405-17. PubMed ID: 11214751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG - a versatile conjugating ligand for drugs and drug delivery systems.
    Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A
    J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation and HAylation via catechol: α-Amine-specific reaction at N-terminus of peptides and proteins.
    Song IT; Lee M; Lee H; Han J; Jang JH; Lee MS; Koh GY; Lee H
    Acta Biomater; 2016 Oct; 43():50-60. PubMed ID: 27424082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylation for improving the effectiveness of therapeutic biomolecules.
    Pasut G; Veronese FM
    Drugs Today (Barc); 2009 Sep; 45(9):687-95. PubMed ID: 19956810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics.
    Erak M; Bellmann-Sickert K; Els-Heindl S; Beck-Sickinger AG
    Bioorg Med Chem; 2018 Jun; 26(10):2759-2765. PubMed ID: 29395804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.